Shimadzu Opens "Laboratory World" in Germany
Shimadzu officially opened a new laboratory building called ?Laboratory World? at the company?s headquarters in Duisberg, Germany on the 15th of April,. The building was officially opened in a traditional Japanese ceremony by the President and CEO of Shimadzu, Akira Nakamoto; the Japanese Consul, Kiyoshi Koinuma; and Duisberg?s Lord Mayor, Soren Link.
Shimadzu officially opened a new laboratory building called “Laboratory World” at the company’s headquarters in Duisberg, Germany on the 15th of April. The building was officially opened in a traditional Japanese ceremony by the President and CEO of Shimadzu, Akira Nakamoto; the Japanese Consul, Kiyoshi Koinuma; and Duisberg’s Lord Mayor, Soren Link.
Shimadzu invested €3.2 million into the laboratory that covers over 1,500m 2. The laboratory features training and testing facilities for scientists throughout Europe. The entire product range offered by Shimadzu will be available for demonstration, with an area specially dedicated to mass spectrometry technology and instrumentation.
The laboratory will provide a range of opportunities for Shimadzu and customers, according to Jürgen Kwass, Managing Director of Shimadzu Europa. Kwass added, ”In addition, we offer continuing education and training to customers as well as staff members. Another goal is to create an inspiring atmosphere for our team in which they can develop new methods and technologies for future-oriented products."
For more information please visit:
www.shimadzu.eu
href="http://images2.advanstar.com/PixelMags/lctc/digitaledition/May02-2013.html ">This story originally appeared in
The Column.
Click here to view that issue.
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.
